Dianthus Therapeutics

Develops monoclonal antibody therapies for patients with autoimmune diseases.

Discussion
BiotechnologyPharmaceuticals dianthustx.com ↗

Company facts

Founded
2019
Employees
96
Headquarters
United States
Type
Public
Listed
NASDAQ: DNTH
Subsidiaries
Dianthus Therapeutics OpCo, Inc.